Oct 2020: All 13 participating hospital departments of CLEO study are in intervention phase!
1 okt 2020
13 hospital departments of 3 countries participate in CLEO (Clinical Evaluation of DeltaScan). CLEO has a stepped wedge design, so some departments had a short control phase and a long intervention phase and others the opposite. Since 1 October 2020 all participants are in the control phase, meaning that DeltaScan is used for detection and monitoring for delirium.
This milestone was “celebrated” with an attractively designed 2-page CLEO newsletter, that was sent to all participants. The German centers received it in German language, the Dutch and Belgian centers in Dutch.
![](http://deltascanproject.eu/wp-content/uploads/2021/01/CLEO-Nieuwsbrief-DE-okt-2020_Page_1.jpg)
![](http://deltascanproject.eu/wp-content/uploads/2021/01/CLEO-Nieuwsbrief-DE-okt-2020_Page_2.jpg)
Back to all news items
Prolira B.V.
Padualaan 8
3584 CH Utrecht
The Netherlands
tel: +31 (0)6 2297 8972
info@prolira.com